The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?
- 1 September 2016
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 35 (9) , 1057-1058
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Humoral responses after lung transplantationCurrent Opinion in Organ Transplantation, 2016
- Bronchiolitis obliterans syndrome due to donor‐specific HLA‐antibodiesTissue Antigens, 2015
- Current views on chronic rejection after lung transplantationTransplant International, 2015
- Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantationThe Journal of Heart and Lung Transplantation, 2015
- De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart–Lung Transplant Report—2014; Focus Theme: RetransplantationThe Journal of Heart and Lung Transplantation, 2014
- A new classification system for chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2014
- Implications for Human Leukocyte Antigen Antibodies After Lung TransplantationChest, 2013
- Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantationThe Journal of Heart and Lung Transplantation, 2010